PMDA — authorised 25 March 2020
- Marketing authorisation holder: Sumitomo Dainippon Pharma Co., Ltd.
- Status: approved
🇯🇵 Latuda in Japan
PMDA authorised Latuda on 25 March 2020
Marketing authorisation
Latuda in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Latuda approved in Japan?
Yes. PMDA authorised it on 25 March 2020.
Who is the marketing authorisation holder for Latuda in Japan?
Sumitomo Dainippon Pharma Co., Ltd. holds the Japanese marketing authorisation.